Omnicell to Acquire Pharmaceutical Strategy Group’s 340B Link Business

Posted on August 2, 2020

Read Time: 0 min

Plano, Texas – Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business. You’ll find all the details at omnicell.com.

News

Press Release

PSG Expands With Move To New Space At The Campus At Legacy In Plano, Tx

PLANO, TX – Plano-based Pharmaceutical Strategies Group — which doubled in size in the past two years — recently moved into its new headquarters at…

Read Post
Press Release

Artemetrx recognized as one of the most promising data analytics solutions providers

Plano, TX – (May 25, 2017) – Artemetrx, a provider of advanced analytics and specialty drug cost management solutions, was named as one of the…

Read Post
Press Release

Manged Care Innovator: Jane Lutz

Issue: March 2018 – FRMC PSG’s Pharmacy Benefit Management Institute (PBMI) is an independent research and education organization that focuses on the complexities…

Read Post

Omnicell to Acquire Pharmaceutical Strategy Group’s 340B Link Business

Related Posts